2025-05-21-Jefferies-5月30日周五上午10点关键意见领袖电话会议PFA市场最新情况_8页_143kb

KOL Call Event: Scheduled for Friday, May 30, at 10am ET, featuring Dr. Jonathan Hsu, an electrophysiologist, to discuss PFA market trends, market share expectations, mapping space dynamics, LAAC volume trends, and innovations in pacing and ICDs. Registration link provided.

Relevant Companies: Abbott Laboratories (ABT), Boston Scientific Corp (BSX), Medtronic PLC (MDT).

Abbott Laboratories (ABT): Price target $137 based on ~24x 2026E EPS. Downside risks include slowing procedures, increased competition, litigation, and macro issues like tariffs. Upside risks include faster procedure growth, strong product launches, M&A, and improved macro conditions.

Boston Scientific Corp (BSX): Price target $122 based on 37x 2026E EPS. Downside risks include elective procedure pressure, macro headwinds, product delays, taxes, and competition. Upside risks include faster procedure growth and product rollouts in areas like TAVR.

Medtronic PLC (MDT): Price target $90 based on 16x 2026E EPS. Downside risks include slower procedure growth, regulatory delays, competition, and inflation. Upside risks include faster procedure growth and product innovations in specific therapeutic areas.

Investment Recommendations: ABT HOLD, BSX BUY, MDT HOLD. Analysts provide ratings based on fundamental analysis, with tools like price targets and historical performance charts.

Key Analysts: Michael Sarcone, Matthew Taylor, Young Li, Michael Toomey, Matthew Aspro, covering the equity research. Disclosure includes potential conflicts of interest and compensation links to firm performance.